Obsidio, Inc.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Obsidio, Inc. is a venture-backed medical device startup that has developed a shear-thinning, injectable, hydrogel platform technology that targets a wide range of clinical needs, including vascular embolization, interventional oncology, regenerative medicine, and controlled locoregional drug delivery. It offers key benefits, including ready to use injectability via a wide range of catheters and needles, time-insensitive delivery, multi-drug loading of small and large molecules and spontaneous depot formation, visibility under MRI, CT and ultrasound, and controlled degradation profile.
Speaker
photo
CEO
Obsidio, Inc.